Log in

Vanda Pharmaceuticals News Headlines (NASDAQ:VNDA)

$13.42
-0.03 (-0.22 %)
(As of 02/21/2020 02:21 AM ET)
Today's Range
$13.17
Now: $13.42
$13.65
50-Day Range
$12.68
MA: $14.33
$16.80
52-Week Range
$11.83
Now: $13.42
$21.41
Volume293,632 shs
Average Volume499,492 shs
Market Capitalization$715.78 million
P/E Ratio6.02
Dividend YieldN/A
Beta0.27

Headlines

Vanda Pharmaceuticals (NASDAQ VNDA) News Headlines

Source:
DateHeadline
Vanda Pharmaceuticals (VNDA) to Release Earnings on TuesdayVanda Pharmaceuticals (VNDA) to Release Earnings on Tuesday
www.americanbankingnews.com - February 19 at 12:41 PM
Vanda Pharmaceuticals Appoints Stephen Ray Mitchell to Board of DirectorsVanda Pharmaceuticals Appoints Stephen Ray Mitchell to Board of Directors
finance.yahoo.com - February 19 at 9:18 AM
Vanda Pharmaceuticals to Announce Fourth Quarter...Vanda Pharmaceuticals to Announce Fourth Quarter...
www.benzinga.com - February 18 at 10:45 PM
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020
www.prnewswire.com - February 18 at 9:43 PM
Zacks: Brokerages Anticipate Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Will Announce Quarterly Sales of $59.77 MillionZacks: Brokerages Anticipate Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Will Announce Quarterly Sales of $59.77 Million
www.americanbankingnews.com - February 11 at 5:36 AM
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Expected to Post Earnings of $0.12 Per ShareVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Expected to Post Earnings of $0.12 Per Share
www.americanbankingnews.com - February 9 at 4:42 AM
Vanda Loses Against The FDA, And Other News: The Good, Bad, And Ugly Of BiopharmaVanda Loses Against The FDA, And Other News: The Good, Bad, And Ugly Of Biopharma
seekingalpha.com - February 4 at 7:38 PM
Court rules against Vanda, in favor of FDA on clinical trials suitCourt rules against Vanda, in favor of FDA on clinical trials suit
finance.yahoo.com - February 3 at 6:08 PM
Vanda Pharmaceuticals (NASDAQ:VNDA) Earns "Hold" Rating from Stifel NicolausVanda Pharmaceuticals (NASDAQ:VNDA) Earns "Hold" Rating from Stifel Nicolaus
www.americanbankingnews.com - February 3 at 1:09 PM
Vanda comes up short in lawsuit with FDA over tradipitantVanda comes up short in lawsuit with FDA over tradipitant
seekingalpha.com - February 1 at 6:12 PM
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Given Consensus Rating of "Hold" by BrokeragesVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - February 1 at 10:25 AM
Vanda Pharmaceuticals Comments on Court RulingVanda Pharmaceuticals Comments on Court Ruling
finance.yahoo.com - January 31 at 6:59 PM
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 10.3% in JanuaryVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 10.3% in January
www.americanbankingnews.com - January 29 at 5:55 AM
Vanda’s patent challenge over its schizophrenia drug is finally over. But its not their only generics threat.Vanda’s patent challenge over its schizophrenia drug is finally over. But it's not their only generics threat.
www.bizjournals.com - January 16 at 6:47 PM
Vanda’s patent challenge over its schizophrenia drug is finally over. But it's not their only generics threat.Vanda’s patent challenge over its schizophrenia drug is finally over. But it's not their only generics threat.
finance.yahoo.com - January 16 at 6:47 PM
Vanda Pharma prevails in Fanapt patent challengeVanda Pharma prevails in Fanapt patent challenge
seekingalpha.com - January 13 at 4:00 PM
Vanda Pharmaceuticals Wins Key U.S. Supreme Court Patent Ruling on Fanapt®Vanda Pharmaceuticals Wins Key U.S. Supreme Court Patent Ruling on Fanapt®
finance.yahoo.com - January 13 at 4:00 PM
Do Vanda Pharmaceuticalss (NASDAQ:VNDA) Earnings Warrant Your Attention?Do Vanda Pharmaceuticals's (NASDAQ:VNDA) Earnings Warrant Your Attention?
finance.yahoo.com - December 23 at 5:57 PM
Do Vanda Pharmaceuticals's (NASDAQ:VNDA) Earnings Warrant Your Attention?Do Vanda Pharmaceuticals's (NASDAQ:VNDA) Earnings Warrant Your Attention?
finance.yahoo.com - December 23 at 5:57 PM
Mihael H. Polymeropoulos, MD, President and CEO of Vanda Pharmaceuticals Inc., to Receive The Physicians Committee for Responsible Medicine Trailblazer AwardMihael H. Polymeropoulos, MD, President and CEO of Vanda Pharmaceuticals Inc., to Receive The Physicians Committee for Responsible Medicine Trailblazer Award
finance.yahoo.com - December 12 at 5:22 PM
Vanda Pharmaceuticals Inc. (VNDA): Hedge Funds In Wait-and-See ModeVanda Pharmaceuticals Inc. (VNDA): Hedge Funds In Wait-and-See Mode
finance.yahoo.com - December 10 at 11:33 PM
Vanda Pharmaceuticals (VNDA) Presents At Stifel Healthcare Conference - SlideshowVanda Pharmaceuticals (VNDA) Presents At Stifel Healthcare Conference - Slideshow
seekingalpha.com - November 22 at 7:00 PM
Vanda Pharmaceuticals Announces Participation at November 2019 Investor ConferencesVanda Pharmaceuticals Announces Participation at November 2019 Investor Conferences
finance.yahoo.com - November 18 at 8:15 PM
Edited Transcript of VNDA earnings conference call or presentation 6-Nov-19 9:30pm GMTEdited Transcript of VNDA earnings conference call or presentation 6-Nov-19 9:30pm GMT
finance.yahoo.com - November 13 at 9:01 PM
Vanda Pharmaceuticals (VNDA) CEO Mihales Polymeropoulos on Q3 2019 Results - Earnings Call TranscriptVanda Pharmaceuticals' (VNDA) CEO Mihales Polymeropoulos on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 9:11 PM
Vanda Pharmaceuticals (VNDA) Q3 2019 Earnings Call TranscriptVanda Pharmaceuticals (VNDA) Q3 2019 Earnings Call Transcript
www.nasdaq.com - November 8 at 12:04 AM
Vanda Pharmaceuticals EPS of $1.84Vanda Pharmaceuticals EPS of $1.84
seekingalpha.com - November 6 at 6:12 PM
Vanda Pharmaceuticals Reports Third Quarter 2019 Financial ResultsVanda Pharmaceuticals Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 6 at 6:12 PM
Hedge Funds Have Never Been Less Bullish On Vanda Pharmaceuticals Inc. (VNDA)Hedge Funds Have Never Been Less Bullish On Vanda Pharmaceuticals Inc. (VNDA)
finance.yahoo.com - October 31 at 1:58 PM
Vanda Pharmaceuticals to Announce Third Quarter 2019 Financial Results on November 6, 2019Vanda Pharmaceuticals to Announce Third Quarter 2019 Financial Results on November 6, 2019
finance.yahoo.com - October 30 at 5:31 PM
Vanda Pharmaceuticals Appoints Anne Sempowski Ward to Board of DirectorsVanda Pharmaceuticals Appoints Anne Sempowski Ward to Board of Directors
www.prnewswire.com - October 28 at 4:34 PM
Vanda Announces New Study Results Showing a High Degree of Inbreeding in Beagle DogsVanda Announces New Study Results Showing a High Degree of Inbreeding in Beagle Dogs
finance.yahoo.com - October 23 at 5:39 PM
Vanda Applauds White House Issuance of Executive Orders Requiring Federal Agencies to be Transparent in Policymaking and EnforcementVanda Applauds White House Issuance of Executive Orders Requiring Federal Agencies to be Transparent in Policymaking and Enforcement
finance.yahoo.com - October 16 at 6:39 PM
SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles Announces that Vanda Pharmaceuticals Inc. (VNDA) Sued for Misleading Investors; Shareholders Urged to Contact the FirmSHAREHOLDER ALERT: The Law Offices of Timothy L. Miles Announces that Vanda Pharmaceuticals Inc. (VNDA) Sued for Misleading Investors; Shareholders Urged to Contact the Firm
finance.yahoo.com - October 15 at 1:24 PM
Volatility 101: Should Vanda Pharmaceuticals (NASDAQ:VNDA) Shares Have Dropped 42%?Volatility 101: Should Vanda Pharmaceuticals (NASDAQ:VNDA) Shares Have Dropped 42%?
finance.yahoo.com - October 10 at 2:17 PM
Vanda Pharmaceuticals Applauds the EPAs Landmark Commitment to Eliminate Animal Testing and Urges the Food and Drug Administration to End Unnecessary and Scientifically Flawed Animal Toxicity StudiesVanda Pharmaceuticals Applauds the EPA's Landmark Commitment to Eliminate Animal Testing and Urges the Food and Drug Administration to End Unnecessary and Scientifically Flawed Animal Toxicity Studies
www.prnewswire.com - September 11 at 5:34 PM
Here's What We Think About Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) CEO PayHere's What We Think About Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) CEO Pay
finance.yahoo.com - September 4 at 5:00 PM
Vanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketing OfficerVanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketing Officer
finance.yahoo.com - August 21 at 10:13 AM
A $1,500 drug that claims to cure jet lag has been held up by the FDAA $1,500 drug that claims to cure jet lag has been held up by the FDA
www.businessinsider.com - August 19 at 10:22 PM
FDA Issues Complete Response For Vandas Hetlioz In Jet Lag DisorderFDA Issues Complete Response For Vanda's Hetlioz In Jet Lag Disorder
finance.yahoo.com - August 19 at 5:22 PM
FDA rejects Vanda’s drug application for jet lag disorderFDA rejects Vanda’s drug application for jet lag disorder
finance.yahoo.com - August 19 at 5:22 PM
Why the FDA Is a Little Slow on This Jet Lag StudyWhy the FDA Is a Little Slow on This Jet Lag Study
247wallst.com - August 19 at 11:02 AM
FDA rejects Vandas Hetlioz for jet lag disorderFDA rejects Vanda's Hetlioz for jet lag disorder
seekingalpha.com - August 19 at 11:02 AM
Biotech Stock On The Radar: Is Vanda A Buy Ahead Of Its PDUFA Date?Biotech Stock On The Radar: Is Vanda A Buy Ahead Of Its PDUFA Date?
www.benzinga.com - August 13 at 5:01 PM
The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPOThe Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO
www.benzinga.com - August 11 at 4:24 PM
Why Vanda (VNDA) Might be Well Poised for a SurgeWhy Vanda (VNDA) Might be Well Poised for a Surge
finance.yahoo.com - August 8 at 11:19 AM
Should You Be Worried About Insider Transactions At Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)?Should You Be Worried About Insider Transactions At Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)?
finance.yahoo.com - August 5 at 5:11 PM
Vanda Pharmaceuticals Returns to Profitability in Q2Vanda Pharmaceuticals Returns to Profitability in Q2
finance.yahoo.com - August 5 at 5:11 PM
Edited Transcript of VNDA earnings conference call or presentation 31-Jul-19 8:30pm GMTEdited Transcript of VNDA earnings conference call or presentation 31-Jul-19 8:30pm GMT
finance.yahoo.com - August 3 at 4:31 PM
This D.C. biotech has hit some bumps this year. It’s also breaking revenue records.This D.C. biotech has hit some bumps this year. It’s also breaking revenue records.
finance.yahoo.com - August 2 at 4:53 PM
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Featured Article: What is a stock buyback?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel